It has been reported that IL-10 treatment produces beneficial effects in controlling adverse cardiac remodeling following pressure overload or acute myocardial infarction in rodents(Krishnamurthy et al., 2009; Verma et al., 2012; Jung et al., 2017). The gene discussed is IL10; the disease is myocardial infarction.